Ken Davis

President and CEO, Mount Sinai Health System (Festival Underwriter); Trustee, The Aspen Institute

Ken Davis is CEO and president of Mount Sinai Health System. He is a leader in the move away from fee-for-service medicine to population health, keeping more patients healthy and out of the hospital. As a neurobiologist, his Alzheimer’s disease research led the FDA to approve three of the first four treatment drugs on the market. An elected member of the Institute of Medicine and author of more than 575 scientific articles, Davis is a highly cited researcher in the field of brain diseases. His numerous honors include the George H. W. Bush Lifetime of Leadership Award from Yale University. He is a trustee of the Aspen Institute.

Videos/Audio of Ken Davis

Presented in partnership with the National Constitution Center. See more
Featured scholar: Rubayat Khan // As information technology and data management continue their rapid leap forward, we... See more
Income inequality and education disparity between the middle class and the underserved has grown more pronounced over... See more
Businesses — and their leaders — almost universally recognize the importance of learning from failure. But what are the... See more
Healthcare costs are rising more slowly than at any time in the last fifty years, but Americans think they are actually... See more
Will open source platforms drive faster drug delivery to market? How do regulators keep up with those sorts of... See more

Pages